title: Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression.
abstract: Gene therapy for congenital protein deficiencies requires lifelong expression of a deficient protein. Current gene therapy approaches preferentially employ the strong cytomegalovirus (CMV) promoter/enhancer or its derivative CAG promoter; however, these promoters provide only temporary transgene expression. To create a promoter that enables long-lasting expression in muscle, hybrid promoters were constructed by coupling the muscle creatine kinase (MCK) enhancer to various strong promoters for enhancement of tissue specificity and improved transcriptional activity. A hybrid promoter containing the MCK enhancer and the simian virus 40 promoter (MCK/SV40 promoter) yielded long-term (>6 months) expression of a human secretory alkaline phosphatase (huSEAP) reporter gene following electrotransfer of the plasmid into mice, whereas expression using a conventional CMV or CAG promoter faded away within a few weeks. To explore the mechanism behind the sustained expression obtained with the MCK/SV40 promoter, mice were immunized with a LacZ expression plasmid driven by MCK/SV40 or a conventional promoter. Minimal cellular and humoral responses to LacZ were observed in MCK/SV40 promoter-treated animals, and mouse SEAP gene expression in vivo was successfully maintained by both the MCK/SV40 and conventional promoters. These results suggest that the lower immunogenicity of the MCK/SV40 promoter contributed to long-lasting gene expression in mice. Therefore, the MCK/SV40 promoter may provide the basis for development of an effective transgene expression cassette for treatment of congenital protein deficiencies in which therapeutic proteins are recognized as foreign by the host immune system.
authors.affiliation: Department of Molecular Biodefense Research, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. takesita@yokohama-cu.ac.jp
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Takeshita
authors.forename: Keiko
authors.initials: K
authors.lastname: Takase
authors.forename: Miyuki
authors.initials: M
authors.lastname: Tozuka
authors.forename: Sukumar
authors.initials: S
authors.lastname: Saha
authors.forename: Kenji
authors.initials: K
authors.lastname: Okuda
authors.forename: Norihisa
authors.initials: N
authors.lastname: Ishii
authors.forename: Shin
authors.initials: S
authors.lastname: Sasaki
mesh_terms: D000818:Animals; D002460:Cell Line; D052283:Creatine Kinase, MM Form / Q000235:genetics / Q000378:metabolism*; D005260:Female; D015870:Gene Expression / Q000235:genetics*; D006801:Humans; D007125:Immunogenetics; D051379:Mice; D008807:Mice, Inbred BALB C; D011401:Promoter Regions, Genetic / Q000235:genetics*; D015202:Protein Engineering; D013539:Simian virus 40 / Q000235:genetics*; D013997:Time Factors; D019076:Transgenes / Q000235:genetics*
chemical_list: D052283:Creatine Kinase, MM Form